New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?

Bibliography

• Goldring MB. Chondrogenesis, chondrocyte differentiation, and articular cartilage metabolism in health and osteoarthritis. Ther Adv Musculoskelet Dis 2012;4:269-85
   PubMedGoogle Scholar
• Jelic M, Pecina M, Haspl M, et al. Regeneration of articular cartilage chondral defects by osteogenic protein-1 (bone morphogenetic protein-7) in sheep. Growth Factors 2001;19:101-13
   PubMed Web of Science ®Google Scholar
• Gavenis K, Heussen N, Schmidt-Rohlfing B. Effects of low concentration BMP-7 on human osteoarthritic chondrocytes: comparison of different applications. J Biomater Appl 2012;26:845-59
   Google Scholar
• Hunter DJ, Pike MC, Jonas BL, et al. Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis. BMC Musculoskelet Disord 2010;11:232
   PubMed Web of Science ®Google Scholar
• Available from: www.clinicaltrials.gov/
   Google Scholar
• Moore EE, Bendele AM, Thompson DL, et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthritis Cartilage 2005;13:623-31
   PubMed Web of Science ®Google Scholar
• McPherson R, Flechsenhar K, Hellot S, et al. A randomized, double-blind, placebo-controlled, multicenter study of rhFGF18 administered intraarticularly using single or multiple ascending doses in patients with primary knee osteoarthritis (OA), not expected to require knee surgery within 1 year. Osteoarthritis Cartilage 2011;19(Suppl 1):S35-S6
   Google Scholar
• Pietrzak WS, An YH, Kang QK, et al. Platelet-rich and platelet-poor plasma: development of an animal model to evaluate hemostatic efficacy. J Craniofac Surg 2007;18:559-67
   PubMed Web of Science ®Google Scholar
• Anitua E, Andia I, Ardanza B, et al. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004;91:4-15
   PubMed Web of Science ®Google Scholar
• Dhillon RS, Schwarz EM, Maloney MD. Platelet-rich plasma therapy - future or trend? Arthritis Res Ther 2012;14:219
   PubMed Web of Science ®Google Scholar
• Patel S, Dhillon MS, Aggarwal S, et al. Treatment with platelet-rich plasma is more effective than placebo for knee osteoarthritis: a prospective, double-blind, randomized trial. Am J Sports Med 2013;41:356-64
   PubMed Web of Science ®Google Scholar
• Taylor DW, Petrera M, Hendry M, et al. A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med 2011;21:344-52
   PubMed Web of Science ®Google Scholar
• Kon E, Mandelbaum B, Buda R, et al. Platelet-rich plasma intra-articular injection versus hyaluronic acid viscosupplementation as treatments for cartilage pathology: from early degeneration to osteoarthritis. Arthroscopy 2011;27:1490-501
   PubMed Web of Science ®Google Scholar
• Kon E, Buda R, Filardo G, et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 2010;18:472-9
   PubMed Web of Science ®Google Scholar
• Sampson S, Reed M, Silvers H, et al. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil 2010;89:961-9
   PubMed Web of Science ®Google Scholar
• Sanchez M, Anitua E, Azofra J, et al. Intra-articular injection of an autologous preparation rich in growth factors for the treatment of knee OA: a retrospective cohort study. Clin Exp Rheumatol 2008;26:910-13
   PubMed Web of Science ®Google Scholar
• Filardo G, Kon E, Di Martino A, et al. Platelet-rich plasma vs hyaluronic acid to treat knee degenerative pathology: study design and preliminary results of a randomized controlled trial. BMC Musculoskelet Disord 2012;13:229
   PubMed Web of Science ®Google Scholar
• Spakova T, Rosocha J, Lacko M, et al. Treatment of knee joint osteoarthritis with autologous platelet-rich plasma in comparison with hyaluronic acid. Am J Phys Med Rehabil 2012;91:411-17
   PubMed Web of Science ®Google Scholar
• Sanchez M, Fiz N, Azofra J, et al. A randomized clinical trial evaluating plasma rich in growth factors (PRGF-Endoret) versus hyaluronic acid in the short-term treatment of symptomatic knee osteoarthritis. Arthroscopy 2012;28:1070-8
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Wildi LM, Pelletier JP. Future therapeutics for osteoarthritis. Bone 2012;51:297-311
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Jovanovic D, Fernandes JC, et al. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of inducible nitric oxide synthase. Arthritis Rheum 1998;41:1275-86
   PubMed Web of Science ®Google Scholar
• Hellio le Graverand MP, Clemmer RS, Redifer P, et al. A 2-year randomised, double-blind, placebo-controlled, multicentre study of oral selective iNOS inhibitor, cindunistat (SD-6010), in patients with symptomatic osteoarthritis of the knee. Ann Rheum Dis 2013;72:187-95
   PubMed Web of Science ®Google Scholar
• Muhammad H, Schminke B, Miosge N. Current concepts in stem cell therapy for articular cartilage repair. Expert Opin Biol Ther 2013;13:541-8
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-7
   PubMed Web of Science ®Google Scholar
• Gupta PK, Das AK, Chullikana A, et al. Mesenchymal stem cells for cartilage repair in osteoarthritis. Stem Cell Res Ther 2012;3:25
   PubMed Web of Science ®Google Scholar
• Johnson K, Zhu S, Tremblay MS, et al. A stem cell-based approach to cartilage repair. Science 2012;336:717-21
   PubMed Web of Science ®Google Scholar
• Murphy JM, Fink DJ, Hunziker EB, et al. Stem cell therapy in a caprine model of osteoarthritis. Arthritis Rheum 2003;48:3464-74
   PubMed Web of Science ®Google Scholar
• Grigolo B, Lisignoli G, Desando G, et al. Osteoarthritis treated with mesenchymal stem cells on hyaluronan-based scaffold in rabbit. Tissue Eng Part C Methods 2009;15:647-58
   PubMed Web of Science ®Google Scholar
• Alfaqeh H, Norhamdan MY, Chua KH, et al. Cell based therapy for osteoarthritis in a sheep model: gross and histological assessment. Med J Malaysia 2008;63(Suppl A):37-8
   Google Scholar
• ter Huurne M, Schelbergen R, Blattes R, et al. Antiinflammatory and chondroprotective effects of intraarticular injection of adipose-derived stem cells in experimental osteoarthritis. Arthritis Rheum 2012;64:3604-13
   PubMed Web of Science ®Google Scholar
• Toupet K, Maumus M, Peyrafitte JA, et al. Long-term detection of human adipose derived mesenchymal stem cells after intra-articular injection in SCID mice. Arthritis Rheum 2013;65:1786-94
   PubMed Web of Science ®Google Scholar
• Diekman BO, Guilak F. Stem cell-based therapies for osteoarthritis: challenges and opportunities. Curr Opin Rheumatol 2013;25:119-26
   PubMed Web of Science ®Google Scholar
• Kuroda R, Ishida K, Matsumoto T, et al. Treatment of a full-thickness articular cartilage defect in the femoral condyle of an athlete with autologous bone-marrow stromal cells. Osteoarthritis Cartilage 2007;15:226-31
   PubMed Web of Science ®Google Scholar
• Wakitani S, Nawata M, Tensho K, et al. Repair of articular cartilage defects in the patello-femoral joint with autologous bone marrow mesenchymal cell transplantation: three case reports involving nine defects in five knees. J Tissue Eng Regen Med 2007;1:74-9
   PubMed Web of Science ®Google Scholar
• Davatchi F, Abdollahi BS, Mohyeddin M, et al. Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. Int J Rheum Dis 2011;14:211-15
   PubMed Web of Science ®Google Scholar
• Emadedin M, Aghdami N, Taghiyar L, et al. Intra-articular injection of autologous mesenchymal stem cells in six patients with knee osteoarthritis. Arch Iran Med 2012;15:422-8
   PubMed Web of Science ®Google Scholar
• Koh YG, Jo SB, Kwon OR, et al. Mesenchymal stem cell injections improve symptoms of knee osteoarthritis. Arthroscopy 2013;29:748-55
   PubMed Web of Science ®Google Scholar
• Koh YG, Choi YJ. Infrapatellar fat pad-derived mesenchymal stem cell therapy for knee osteoarthritis. Knee 2012;19:902-7
   PubMed Web of Science ®Google Scholar
• Estes BT, Diekman BO, Gimble JM, et al. Isolation of adipose-derived stem cells and their induction to a chondrogenic phenotype. Nat Protoc 2010;5:1294-311
   PubMed Web of Science ®Google Scholar
• Filardo G, Madry H, Jelic M, et al. Mesenchymal stem cells for the treatment of cartilage lesions: from preclinical findings to clinical application in orthopaedics. Knee Surg Sports Traumatol Arthrosc 2013;21:1717-29
   PubMed Web of Science ®Google Scholar
• Kim HJ, Im GI. Chondrogenic differentiation of adipose tissue-derived mesenchymal stem cells: greater doses of growth factor are necessary. J Orthop Res 2009;27:612-19
   Google Scholar
• Afizah H, Yang Z, Hui JH, et al. A comparison between the chondrogenic potential of human bone marrow stem cells (BMSCs) and adipose-derived stem cells (ADSCs) taken from the same donors. Tissue Eng 2007;13:659-66
   PubMedGoogle Scholar
• Jorgensen C, Noel D. Mesenchymal stem cells in osteoarticular diseases. Regen Med 2011;6:44-51
   PubMedGoogle Scholar
• Roldan M, Macias-Gonzalez M, Garcia R, et al. Obesity short-circuits stemness gene network in human adipose multipotent stem cells. FASEB J 2011;25:4111-26
   PubMed Web of Science ®Google Scholar
• Suri S, Walsh DA. Osteochondral alterations in osteoarthritis. Bone 2012;51:204-11
   PubMed Web of Science ®Google Scholar
• Kwan Tat S, Lajeunesse D, Pelletier JP, et al. Targeting subchondral bone for treating osteoarthritis: what is the evidence? Best Pract Res Clin Rheumatol 2010;24:51-70
   PubMed Web of Science ®Google Scholar
• Lajeunesse D, Pelletier JP, Martel-Pelletier J. Osteoporosis and osteoarthritis: bone is the common battle ground. Medicographia 2010;32:391-8
   Google Scholar
• Pelletier JP, Troncy E, Bertaim T, et al. Treatment with tiludronic acid helps reduce the development of experimental osteoarthritis lesions in dogs with anterior cruciate ligament transection followed by reconstructive surgery: a 1-year study with quantitative magnetic resonance imaging. J Rheumatol 2011;38:118-28
   Google Scholar
• Moreau M, Rialland P, Pelletier JP, et al. Tiludronate treatment improves structural changes and symptoms of osteoarthritis in the canine anterior cruciate ligament model. Arthritis Res Ther 2011;13:R98
   Google Scholar
• Carbone LD, Nevitt MC, Wildy K, et al. The relationship of antiresorptive drug use to structural findings and symptoms of knee osteoarthritis. Arthritis Rheum 2004;50:3516-25
   PubMed Web of Science ®Google Scholar
• Spector TD, Conaghan PG, Buckland-Wright JC, et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther 2005;7:R625-33
   PubMed Web of Science ®Google Scholar
• Bingham CO III, Buckland-Wright JC, Garnero P, et al. Risedronate decreases biochemical markers of cartilage degradation but does not decrease symptoms or slow radiographic progression in patients with medial compartment osteoarthritis of the knee: results of the two-year multinational knee osteoarthritis structural arthritis study. Arthritis Rheum 2006;54:3494-507
   PubMed Web of Science ®Google Scholar
• Tat SK, Pelletier JP, Mineau F, et al. Strontium ranelate inhibits key factors affecting bone remodeling in human osteoarthritic subchondral bone osteoblasts. Bone 2011;49:559-67
   PubMed Web of Science ®Google Scholar
• Henrotin Y, Labasse A, Zheng SX, et al. Strontium ranelate increases cartilage matrix formation. J Bone Miner Res 2001;16:299-308
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Kapoor M, Fahmi H, et al. Strontium ranelate reduces the progression of experimental dog osteoarthritis by inhibiting the expression of key proteases in cartilage and of IL-1beta in the synovium. Ann Rheum Dis 2013;72:250-7
   PubMed Web of Science ®Google Scholar
• Bruyere O, Delferriere D, Roux C, et al. Effects of strontium ranelate on spinal osteoarthritis progression. Ann Rheum Dis 2008;67:335-9
   PubMed Web of Science ®Google Scholar
• Reginster JY, Badurski J, Bellamy N, et al. Efficacy and safety of strontium ranelate in the treatment of knee osteoarthritis: results of a double-blind, randomised placebo-controlled trial. Ann Rheum Dis 2013;72:179-86
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Roubille C, Raynauld JP, et al. Disease modifying effect of strontium ranelate in a phase III knee osteoarthritis study (SEKOIA) using quantitative MRI: reduction in bone marrow lesion size associated with cartilage protective effect. Osteoporos Int 2013;24:S51
   Google Scholar
• Roux C, Richette P. Impact of treatments for osteoporosis on osteoarthritis progression. Osteoporos Int 2012;23(Suppl 8):S881-3
   Google Scholar
• Laslett LL, Dore DA, Quinn SJ, et al. Zoledronic acid reduces knee pain and bone marrow lesions over 1 year: a randomised controlled trial. Ann Rheum Dis 2012;71:1322-8
   PubMed Web of Science ®Google Scholar
• Tat SK, Pelletier JP, Velasco CR, et al. New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target? Keio J Med 2009;58:29-40
   Google Scholar
• Kwan Tat S, Pelletier JP, Lajeunesse D, et al. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol 2008;26:295-304
   Google Scholar
• Kwan Tat S, Amiable N, Pelletier JP, et al. Modulation of OPG, RANK and RANKL by human chondrocytes and their implication during osteoarthritis. Rheumatology (Oxford) 2009;48:1482-90
   PubMed Web of Science ®Google Scholar
• Pilichou A, Papassotiriou I, Michalakakou K, et al. High levels of synovial fluid osteoprotegerin (OPG) and increased serum ratio of receptor activator of nuclear factor-kappa B ligand (RANKL) to OPG correlate with disease severity in patients with primary knee osteoarthritis. Clin Biochem 2008;41:746-9
   PubMed Web of Science ®Google Scholar
• Kadri A, Ea HK, Bazille C, et al. Osteoprotegerin inhibits cartilage degradation through an effect on trabecular bone in murine experimental osteoarthritis. Arthritis Rheum 2008;58:2379-86
   PubMed Web of Science ®Google Scholar
• Josse R, Khan A, Ngui D, et al. Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis. Curr Med Res Opin 2013;29:205-16
   PubMed Web of Science ®Google Scholar
• Cohen SB, Dore RK, Lane NE, et al. Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial. Arthritis Rheum 2008;58:1299-309
   PubMed Web of Science ®Google Scholar
• Hayami T, Zhuo Y, Wesolowski GA, et al. Inhibition of cathepsin K reduces cartilage degeneration in the anterior cruciate ligament transection rabbit and murine models of osteoarthritis. Bone 2012;50:1250-9
   PubMed Web of Science ®Google Scholar
• Sampson ER, Hilton MJ, Tian Y, et al. Teriparatide as a chondroregenerative therapy for injury-induced osteoarthritis. Sci Transl Med 2011;3:101ra93
   PubMed Web of Science ®Google Scholar
• Manicourt DH, Azria M, Mindeholm L, et al. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheum 2006;54:3205-11
   PubMed Web of Science ®Google Scholar
• Esenyel M, Icagasioglu A, Esenyel CZ. Effects of calcitonin on knee osteoarthritis and quality of life. Rheumatol Int 2013;33:423-7
   PubMed Web of Science ®Google Scholar
• Karsdal MA, Alexandersen P, John MR, et al. Oral calcitonin demonstrated symptom-modifying efficacy and increased cartilage volume: results from a 2-year Phase 3 trial in patients with osteoarthritis of the knee. Osteoarthritis Cartilage 2011;19:S35
   Web of Science ®Google Scholar
• Reginster JY, Pelousse F, Bruyere O. Safety concerns with the long-term management of osteoporosis. Expert Opin Drug Saf 2013;12:507-22
   PubMed Web of Science ®Google Scholar
• McAlindon T, LaValley M, Schneider E, et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 2013;309:155-62
   PubMed Web of Science ®Google Scholar
• Cao Y, Jones G, Cicuttini F, et al. Vitamin D supplementation in the management of knee osteoarthritis: study protocol for a randomized controlled trial. Trials 2012;13:131
   Google Scholar
• Kapoor M, Martel-Pelletier J, Lajeunesse D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol 2011;7:33-42
   PubMed Web of Science ®Google Scholar
• Wu X, Kondragunta V, Kornman KS, et al. IL-1 receptor antagonist gene as a predictive biomarker of progression of knee osteoarthritis in a population cohort. Osteoarthritis Cartilage 2013;21:930-8
   PubMed Web of Science ®Google Scholar
• Caron JP, Fernandes JC, Martel-Pelletier J, et al. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum 1996;39:1535-44
   PubMed Web of Science ®Google Scholar
• Chevalier X, Giraudeau B, Conrozier T, et al. Safety study of intraarticular injection of interleukin 1 receptor antagonist in patients with painful knee osteoarthritis: a multicenter study. J Rheumatol 2005;32:1317-23
   PubMed Web of Science ®Google Scholar
• Chevalier X, Goupille P, Beaulieu AD, et al. Intraarticular injection of anakinra in osteoarthritis of the knee: a multicenter, randomized, double-blind, placebo-controlled study. Arthritis Rheum 2009;61:344-52
   PubMed Web of Science ®Google Scholar
• Bacconnier L, Jorgensen C, Fabre S. Erosive osteoarthritis of the hand: clinical experience with anakinra. Ann Rheum Dis 2009;68:1078-9
   PubMed Web of Science ®Google Scholar
• Cohen SB, Proudman S, Kivitz AJ, et al. A randomized, double-blind study of AMG 108 (a fully human monoclonal antibody to IL-1R1) in patients with osteoarthritis of the knee. Arthritis Res Ther 2011;13:R125
   PubMed Web of Science ®Google Scholar
• Chevalier X, Conrozier T, Richette P. Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy. Arthritis Res Ther 2011;13:124
   PubMed Web of Science ®Google Scholar
• Martel-Pelletier J, Pelletier JP. Osteoarthritis: a single injection of anakinra for treating knee OA? Nat Rev Rheumatol 2009;5:363-4
   PubMed Web of Science ®Google Scholar
• Yang KG, Raijmakers NJ, van Arkel ER, et al. Autologous interleukin-1 receptor antagonist improves function and symptoms in osteoarthritis when compared to placebo in a prospective randomized controlled trial. Osteoarthritis Cartilage 2008;16:498-505
   PubMed Web of Science ®Google Scholar
• Baltzer AW, Moser C, Jansen SA, et al. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage 2009;17:152-60
   PubMed Web of Science ®Google Scholar
• Fioravanti A, Fabbroni M, Cerase A, et al. Treatment of erosive osteoarthritis of the hands by intra-articular infliximab injections: a pilot study. Rheumatol Int 2009;29:961-5
   PubMed Web of Science ®Google Scholar
• Magnano MD, Chakravarty EF, Broudy C, et al. A pilot study of tumor necrosis factor inhibition in erosive/inflammatory osteoarthritis of the hands. J Rheumatol 2007;34:1323-7
   PubMed Web of Science ®Google Scholar
• Verbruggen G, Wittoek R, Vander Cruyssen B, et al. Tumour necrosis factor blockade for the treatment of erosive osteoarthritis of the interphalangeal finger joints: a double blind, randomised trial on structure modification. Ann Rheum Dis 2012;71:891-8
   PubMed Web of Science ®Google Scholar
• Chevalier X, Ravaud P, Maheu E, et al. A randomized, multicentre, double blind, placebo-controlled trial of antiTNFalpha (adalimumab) in refractory hand osteoarthritis: the Dora study. Arthritis Rheum 2012;64:S1042
   Google Scholar
• Maksymowych WP, Russell AS, Chiu P, et al. Targeting tumour necrosis factor alleviates signs and symptoms of inflammatory osteoarthritis of the knee. Arthritis Res Ther 2012;14:R206
   PubMed Web of Science ®Google Scholar
• Chevalier X, Eymard F, Richette P. Biologic agents in osteoarthritis: hopes and disappointments. Nat Rev Rheumatol 2013;9:400-10
   PubMed Web of Science ®Google Scholar
• Bondeson J, Wainwright SD, Lauder S, et al. The role of synovial macrophages and macrophage-produced cytokines in driving aggrecanases, matrix metalloproteinases, and other destructive and inflammatory responses in osteoarthritis. Arthritis Res Ther 2006;8:R187
   PubMed Web of Science ®Google Scholar
• Tsuneyoshi Y, Tanaka M, Nagai T, et al. Functional folate receptor beta-expressing macrophages in osteoarthritis synovium and their M1/M2 expression profiles. Scand J Rheumatol 2012;41:132-40
   PubMed Web of Science ®Google Scholar
• Yusuf E, Ioan-Facsinay A, Bijsterbosch J, et al. Association between leptin, adiponectin and resistin and long-term progression of hand osteoarthritis. Ann Rheum Dis 2011;70:1282-4
   PubMed Web of Science ®Google Scholar
• de Boer TN, van Spil WE, Huisman AM, et al. Serum adipokines in osteoarthritis; comparison with controls and relationship with local parameters of synovial inflammation and cartilage damage. Osteoarthritis Cartilage 2012;20:846-53
   PubMed Web of Science ®Google Scholar
• Kyrkanides S, Tallents RH, Miller JN, et al. Osteoarthritis accelerates and exacerbates Alzheimer's disease pathology in mice. J Neuroinflammation 2011;8:112
   PubMed Web of Science ®Google Scholar
• Berenbaum F. Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!). Osteoarthritis Cartilage 2013;21:16-21
   PubMed Web of Science ®Google Scholar
• Evans CH, Ghivizzani SC, Robbins PD. Arthritis gene therapy and its tortuous path into the clinic. Transl Res 2013;161:205-16
   PubMed Web of Science ®Google Scholar
• Pelletier JP, Caron JP, Evans C, et al. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy. Arthritis Rheum 1997;40:1012-19
   PubMed Web of Science ®Google Scholar
• Fernandes J, Tardif G, Martel-Pelletier J, et al. In vivo transfer of interleukin-1 receptor antagonist gene in osteoarthritic rabbit knee joints: prevention of osteoarthritis progression. Am J Pathol 1999;154:1159-69
   PubMed Web of Science ®Google Scholar
• Bakker AC, Joosten LA, Arntz OJ, et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 1997;40:893-900
   PubMed Web of Science ®Google Scholar
• Otani K, Nita I, Macaulay W, et al. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 1996;156:3558-62
   PubMed Web of Science ®Google Scholar
• Evans CH, Robbins PD, Ghivizzani SC, et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Hum Gene Ther 1996;7:1261-80
   PubMed Web of Science ®Google Scholar
• Evans CH, Robbins PD, Ghivizzani SC, et al. Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci USA 2005;102:8698-703
   PubMed Web of Science ®Google Scholar
• Ha CW, Noh MJ, Choi KB, et al. Initial phase I safety of retrovirally transduced human chondrocytes expressing transforming growth factor-beta-1 in degenerative arthritis patients. Cytotherapy 2012;14:247-56
   PubMed Web of Science ®Google Scholar
• Gouze E, Gouze JN, Palmer GD, et al. Transgene persistence and cell turnover in the diarthrodial joint: implications for gene therapy of chronic joint diseases. Mol Ther 2007;15:1114-20
   PubMed Web of Science ®Google Scholar
• Kay JD, Gouze E, Oligino TJ, et al. Intra-articular gene delivery and expression of interleukin-1Ra mediated by self-complementary adeno-associated virus. J Gene Med 2009;11:605-14
   PubMed Web of Science ®Google Scholar
• Watson RS, Broome TA, Levings PP, et al. scAAV-mediated gene transfer of interleukin-1-receptor antagonist to synovium and articular cartilage in large mammalian joints. Gene Ther 2013;20(6):670-7
   Google Scholar
• Apparailly F, Jorgensen C. siRNA-based therapeutic approaches for rheumatic diseases. Nat Rev Rheumatol 2013;9:56-62
   PubMed Web of Science ®Google Scholar
• Santangelo KS, Bertone AL. Effective reduction of the interleukin-1beta transcript in osteoarthritis-prone guinea pig chondrocytes via short hairpin RNA mediated RNA interference influences gene expression of mediators implicated in disease pathogenesis. Osteoarthritis Cartilage 2011;19:1449-57
   PubMed Web of Science ®Google Scholar
• Chen LX, Lin L, Wang HJ, et al. Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. Osteoarthritis Cartilage 2008;16:174-84
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97
   PubMed Web of Science ®Google Scholar
• Xu J, Kang Y, Liao WM, et al. MiR-194 regulates chondrogenic differentiation of human adipose-derived stem cells by targeting Sox5. PLoS One 2012;7:e31861
   PubMedGoogle Scholar
• Tardif G, Hum D, Pelletier JP, et al. Regulation of the IGFBP-5 and MMP-13 genes by the microRNAs miR-140 and miR-27a in human osteoarthritic chondrocytes. BMC Musculoskelet Disord 2009;10:148
   PubMed Web of Science ®Google Scholar
• Miyaki S, Sato T, Inoue A, et al. MicroRNA-140 plays dual roles in both cartilage development and homeostasis. Genes Dev 2010;24:1173-85
   PubMed Web of Science ®Google Scholar
• Yamasaki K, Nakasa T, Miyaki S, et al. Expression of MicroRNA-146a in osteoarthritis cartilage. Arthritis Rheum 2009;60:1035-41
   PubMed Web of Science ®Google Scholar
• Miyaki S, Asahara H. Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol 2012;8:543-52
   PubMed Web of Science ®Google Scholar
• Pers YM, Jorgensen C. MicroRNA in 2012: Biotherapeutic potential of microRNAs in rheumatic diseases. Nat Rev Rheumatol 2013;9:76-8
   Google Scholar
• Dodin P, Abram F, Pelletier JP, et al. A fully automated system for quantification of knee bone marrow lesions using MRI and the Osteoarthritis Initiative cohort. J Biomed Graph Comput 2013;3:51-65
   Google Scholar
• Dodin P, Martel-Pelletier J, Pelletier JP, et al. A fully automated human knee 3D MRI bone segmentation using the ray casting technique. Med Biol Eng Comput 2011;49:1413-24
   Google Scholar
• Dodin P, Pelletier JP, Martel-Pelletier J, et al. Automatic human knee cartilage segmentation from 3D magnetic resonance images. IEEE Trans Biomed Eng 2010;57:2699-711
   Google Scholar
• Li W, Abram F, Pelletier JP, et al. Fully automated system for the quantification of human osteoarthritic knee joint effusion volume using magnetic resonance imaging. Arthritis Res Ther 2010;12:R173
   Google Scholar
• Peeters CM, Leijs MJ, Reijman M, et al. Safety of intra-articular cell-therapy with culture-expanded stem cells in humans: a systematic literature review. Osteoarthritis Cartilage 2013; doi:10.1016/j.joca.2013.06.025
   Google Scholar
• Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2013/04/news_detail_001774.jsp&mid=WC0b01ac058004d5c1
   Google Scholar